QR Insight: Hartalega's Strategic Position Amid Global Health Trends and Opportunities

Navigating the Future

Aug 14, 2023

∙ Paid

In the first quarter of Fiscal Year 2024 (1QFY24), Hartalega Normalised PBT 2 million, in contrast to loss 13 million in the previous quarter (4QFY23). This decline was primarily due to a 14.7% decrease in revenue to RM440.0 million, stemming from a 25.8% reduction in sales volumes. This loss was partly offset by a quarter-over-quarter (QoQ) increase in…

Keep reading with a 7-day free trial

Subscribe to Envision Malaysia 10X stock investment to keep reading this post and get 7 days of free access to the full post archives.